Logo
x

Search

Subscribe Now

Rare disease

Getting on with Rare Disease Therapeutic Options (Orphan Disease Therapies)

Getting on with Rare Disease Therapeutic Options (Orphan Disease Therapies)

  • March 14, 2023
Roche Signs a License Agreement with Shape to Advance AAV-based RNA Editing Technology for Neuroscience and Rare Disease

Roche Signs a License Agreement with Shape to Advance AAV-based RNA Editing Technology for Neuroscience and Rare Disease

  • August 25, 2021
Horizon Therapeutics to Acquire Viela Bio for ~ $3.05B

Horizon Therapeutics to Acquire Viela Bio for ~ $3.05B

  • February 2, 2021
AstraZeneca to Acquire Alexion for $39B

AstraZeneca to Acquire Alexion for $39B

  • December 14, 2020
Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M

Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M

  • March 2, 2020
Pfizer to Acquire Therachon for the Expansion of its Rare Disease Portfolio

Pfizer to Acquire Therachon for the Expansion of its Rare Disease Portfolio

  • May 8, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.